Research programme: COVID-19 compounds - Sunshine Biopharma/University of Georgia
Latest Information Update: 27 Apr 2021
At a glance
- Originator University of Georgia
- Developer Sunshine Biopharma; University of Georgia
- Class Antivirals
- Mechanism of Action Coronavirus papain like protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical COVID 2019 infections